Miccoli P - Search Results

1

All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.

Elisei R, Vivaldi A, Agate L, Ciampi R, Molinaro E, Piampiani P, Romei C, Faviana P, Basolo F, Miccoli P, Capodanno A, Collecchi P, Pacini F, Pinchera A. Elisei R, et al. Among authors: miccoli p. J Clin Endocrinol Metab. 2005 Apr;90(4):2403-11. doi: 10.1210/jc.2004-0969. Epub 2004 Dec 28. J Clin Endocrinol Metab. 2005. PMID: 15623821

2

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F. Elisei R, et al. Among authors: miccoli p. J Clin Endocrinol Metab. 2004 Jan;89(1):163-8. doi: 10.1210/jc.2003-030550. J Clin Endocrinol Metab. 2004. PMID: 14715844

3

Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition.

Elisei R, Cosci B, Romei C, Agate L, Piampiani P, Miccoli P, Berti P, Basolo F, Ugolini C, Ciampi R, Nikiforov Y, Pinchera A. Elisei R, et al. Among authors: miccoli p. J Clin Endocrinol Metab. 2004 Nov;89(11):5823-7. doi: 10.1210/jc.2004-0312. J Clin Endocrinol Metab. 2004. PMID: 15531548

4

RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.

Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, Sculli M, Miccoli P, Basolo F, Grasso L, Pacini F, Pinchera A. Elisei R, et al. Among authors: miccoli p. J Clin Endocrinol Metab. 2007 Dec;92(12):4725-9. doi: 10.1210/jc.2007-1005. Epub 2007 Sep 25. J Clin Endocrinol Metab. 2007. PMID: 17895320

5

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

Elisei R, Cosci B, Romei C, Bottici V, Renzini G, Molinaro E, Agate L, Vivaldi A, Faviana P, Basolo F, Miccoli P, Berti P, Pacini F, Pinchera A. Elisei R, et al. Among authors: miccoli p. J Clin Endocrinol Metab. 2008 Mar;93(3):682-7. doi: 10.1210/jc.2007-1714. Epub 2007 Dec 11. J Clin Endocrinol Metab. 2008. PMID: 18073307

6

BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.

Romei C, Ciampi R, Faviana P, Agate L, Molinaro E, Bottici V, Basolo F, Miccoli P, Pacini F, Pinchera A, Elisei R. Romei C, et al. Among authors: miccoli p. Endocr Relat Cancer. 2008 Jun;15(2):511-20. doi: 10.1677/ERC-07-0130. Endocr Relat Cancer. 2008. PMID: 18509003

7

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.

Elisei R, Ugolini C, Viola D, Lupi C, Biagini A, Giannini R, Romei C, Miccoli P, Pinchera A, Basolo F. Elisei R, et al. Among authors: miccoli p. J Clin Endocrinol Metab. 2008 Oct;93(10):3943-9. doi: 10.1210/jc.2008-0607. Epub 2008 Aug 5. J Clin Endocrinol Metab. 2008. PMID: 18682506

8

Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy.

Miccoli P, Pinchera A, Materazzi G, Biagini A, Berti P, Faviana P, Molinaro E, Viola D, Elisei R. Miccoli P, et al. J Clin Endocrinol Metab. 2009 May;94(5):1618-22. doi: 10.1210/jc.2008-1418. Epub 2009 Feb 17. J Clin Endocrinol Metab. 2009. PMID: 19223525

9

Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.

Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G, Miccoli P, Di Coscio G, Vitti P, Pacini F, Pinchera A. Elisei R, et al. Among authors: miccoli p. J Clin Endocrinol Metab. 2010 Apr;95(4):1516-27. doi: 10.1210/jc.2009-1536. Epub 2010 Feb 15. J Clin Endocrinol Metab. 2010. PMID: 20156922

10

The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.

Elisei R, Romei C, Renzini G, Bottici V, Cosci B, Molinaro E, Agate L, Cappagli V, Miccoli P, Berti P, Faviana P, Ugolini C, Basolo F, Vitti P, Pinchera A. Elisei R, et al. Among authors: miccoli p. J Clin Endocrinol Metab. 2012 Feb;97(2):426-35. doi: 10.1210/jc.2011-2046. Epub 2011 Dec 7. J Clin Endocrinol Metab. 2012. PMID: 22162466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

445 results

Search Page

Filters